Form 4 for BIIB Biogen
Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-06 · accession 0001127602-24-028861 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-09 | 2024-12-09 | BIIB | Singhal Priya | Head of Development | S - Sale+OE | $157.21 | -110 | 5,426 | -2% | -$17.3K |
| D | 2024-12-09 | 2024-12-06 | BIIB | Singhal Priya | Head of Development | F - Tax | $157.78 | -206 | 5,536 | -4% | -$32.5K |
| D | 2024-12-09 | 2024-12-06 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +426 | 5,742 | +8% | $0 |
| D | 2024-12-09 | 2024-12-06 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | -426 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | S | D | 110 | $157.21 | 5,426.48 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-06 | F | D | 206 | $157.78 | 5,536.48 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-06 | M | A | 426 | $0.00 | 5,742.48 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2024-12-06 | M | D | 426 | $0.00 | 0 | D | $0.00 · — to 2024-12-08 | 426 Common Stock | (F1) This award was granted to the reporting person on December 8, 2021 and will vest in three equal installments on each anniversary of the grant date. (F2) This award was granted to the reporting person on February 1, 2023 and will vest in three equal installments on each anniversary of the grant date. |